Christopher P. Filson

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial”.

Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2020.11.038

N/A

1.1DataRank · unranked

21 citations

Fangxin Hong, Traci M. Blonquist, Barbara Halpenny, Niya Xiong, Christopher P. Filson +12 more

Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.11.024

N/A

0DataRank · unranked

36 citations

Ingrid J. Hall, Christopher P. Filson, David H. Howard, Yu Liu

Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.01.002

N/A

0DataRank · unranked

5 citations

Yuan Liu, Theresa Gillespie, Adeboye O. Osunkoya, Bradley Curtis Carthon, Mehmet Asım Bilen +8 more

Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRI

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.07.013

N/A

0DataRank · unranked

1 citations

Dattatraya Patil, Martin G. Sanda, Christopher P. Filson, Jonathan Li

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage

Histopathology(2024)10.1111/his.15231

N/A

0DataRank · unranked

30 citations

Lara R. Harik, Eric A. Klein, Jianbo Li, Dillon Corrigan, Shiguang Liu +18 more